Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells

Molecular Pharmacology

Volumn 75, Issue 1, 2009, Pages 151-157

  Liang, Ji An ^a   Wu, Shih Lu ^c   Lo, Hsin Yi ^c   Hsiang, Chien Yun ^c   Ho, Tin Yun ^b,c  

^a University Hospital   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; VANILLIN; BENZALDEHYDE DERIVATIVE; FORMAZAN; LUCIFERASE; MTT FORMAZAN; TETRAZOLIUM; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL STRAIN HEPG2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; ENZYME INDUCTION; ENZYME REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; BIOLOGICAL MODEL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; LIVER TUMOR; METABOLISM; PATHOLOGY; REPORTER GENE; TUMOR CELL LINE;

BENZALDEHYDES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FORMAZANS; GENES, REPORTER; HUMANS; LIVER NEOPLASMS; LUCIFERASES; MATRIX METALLOPROTEINASE 9; MODELS, BIOLOGICAL; NF-KAPPA B; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS;

EID: 58849158423     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.049502     Document Type: Article

References (40)

1. Aggarwal BB and Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharm 71:1397-1421.
2. Akagi K, Hirose M, Hoshiya T, Mizoguchi Y, Ito N, and Shirai T (1995) Modulating effects of ellagic acid, vanillin and quercetin in a rat medium term multiorgan carcinogenesis model. Cancer Lett 94:113-121.
3. Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M, Mizumoto M, Fukumoto M, and Imamura M (1996) Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24:316-322.
4. Aruoma OI (1999) Antioxidant actions of plant foods: use of oxidative DNA damage as a tool for studying antioxidant efficacy. Free Radic Res 30:419-427.
5. Baldwin AS Jr (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB. J Clin Invest 107:241-246.
6. Banerjee S, Bueso-Ramos C, and Aggarwal BB (2002) Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resvera-trol: role of nuclear factor-κB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62:4945-4954.
7. Barnes PJ and Karin M (1997) Nuclear factor-kB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
8. Barry OP and Kazanietz MG (2001) Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des 7:1725-1744.
9. Blumberg PM, Delclos KB, Dunphy WG, and Jaken S (1982) Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells. Carcinog Compr Surv 7:519-535.
10. Cerrutti P, Alzamora SM, and Vidales SL (1997) Vanillin as an antimicrobial for producing shelf-stable strawberry puree. J Food Sci 62:608-610.
11. Cha HJ, Bae SK, Lee HY, Lee OH, Sato H, Seiki M, Park BC, and Kim KW (1996) Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res 56:2281-2284.
12. Chen HW, Yu SL, Chen JJ, Li HN, Lin YC, Yao PL, Chou HY, Chien CT, Chen WJ, Lee YT, et al. (2004) Antiinvasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol Pharmacol 65:99-110.
13. Cheng WY, Hsiang CY, Bau DT, Chen JC, Shen WS, Li CC, Lo HY, Wu SL, Chiang SY, and Ho TY (2007) Microarray analysis of vanillin-regulated gene expression profile in human hepatocarcinoma cells. Pharmacol Res 56:474-482.
14. Fürstenberger G, Berry DL, Sorg B, and Marks F (1981) Skin tumor promotion by phorbol esters is a two-stage process. Proc Natl Acad Sci USA 78:7722-7726.
15. Garg A and Aggarwal BB (2002) Nuclear transcription factor-κB as a target for cancer drug development. Leukemia 16:1053-1068.
16. Hayasaka A, Suzuki N, Fujimoto N, Iwama S, Fukuyama E, Kanda Y, and Saisho H (1996) Elevated plasma levels of matrix metalloproteinase-9 (92-kd type IV colla-genase/gelatinase B) in hepatocellular carcinoma. Hepatology 24:1058-1062.
17. Hsiang CY, Wu SL, Chen JC, Lo HY, Li CC, Chiang SY, Wu HC, and Ho TY (2007) Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-κB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicol Lett 171:78-86.
18. Hsiang CY, Wu SL, and Ho TY (2005) Morin inhibited 12-O- tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem Pharmacol 69:1603-1611.
19. Huang CS, Fan YE, Lin CY, and Hu ML (2007) Lycopene inhibits matrix metallo-proteinase-9 expression and down-regulates the binding activity of nuclear fac-tor-kB and stimulatory protein-1. J Nutr Biochem 18:449-456.
20. Jansson T and Zech L (1987) Effects of vanillin on sister-chromatid exchanges and chromosome aberrations in human lymphocytes. Mutat Res 190:221-224.
21. Kamat JP, Ghosh A, and Devasagayam TP (2000) Vanillin as an antioxidant in rat liver mitochondria: Inhibition of protein oxidation and lipid peroxidation induced by photosensitization. Mol Cell Biochem 209:47-53.
22. Karin M and Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5:749 -759.
23. Keshava C, Keshava N, Ong TM, and Nath J (1998) Protective effect ofvanillin on radiation-induced micronuclei and chromosomal aberrations in V79 cells. Mutat Res 397:149-159.
24. Lirdprapamongkol K, Sakurai H, Kawasaki N, Choo MK, Saitoh Y, Aozuka Y, Singhirunnusorn P, Ruchirawat S, Svasti J, and Saiki I (2005) Vanillin suppresses in vitro invasion and in vivo metastasis ofmouse breast cancer cells. Eur J Pharm Sci 25:57-65.
25. Liu JF, Crépin M, Liu JM, Barritault D, and Ledoux D (2002) FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293:1174-1182.
26. McNulty SE, del Rosario R, Cen D, Meyskens FL Jr, and Yang S (2004) Comparative expression of NF-κB proteins in melanocytes of normal skin vs. benign intrader-mal naevus and human metastatic melanoma biopsies. Pigment Cell Res 17:173-180.
27. Mortelmans K, Haworth S, Lawlor T, Speck W, Tainer B, and Zeiger E (1986) Salmonella mutagenicity tests. II. Results from the testing of 270 chemicals. Environ Mutagen 8 (Suppl 7):1-119.
28. Murakami Y, Hirata A, Ito S, Shoji M, Tanaka S, Yasui T, Machino M, and Fujisawa S (2007) Re-evaluation of cyclooxygenase-2-inhibiting activity of vanillin and guaiacol in macrophages stimulated with lipopolysaccharide. Anticancer Res 27:801-807.
29. Murono S, Yoshizaki T, Sato H, Takeshita H, Furukawa M, and Pagano JS (2000) Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 60:2555-2561.
30. Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, and Koyanagi Y (2002) Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer. Pancreas 24:169-178.
31. Nelson AR, Fingleton B, Rothenberg ML, and Matrisian LM (2000) Matrix metallo-proteinases: biologic activity and clinical implications. J Clin Oncol 18:1135-1149.
32. Newman DJ, Cragg GM, Holbeck S, and Sausville EA (2002) Natural products and derivatives as leads to cell cycle pathway targets in cancer chemotherapy. Curr Cancer Drug Targets 2:279-308.
33. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau JL, Bezeaud A, Delforge D, Cubizolles M, et al. (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 41:40-47.
34. Rao SR and Ravishankar GA(2000) Vanilla flavour: production by conventional and biotechnological routes. J Sci Food Agric 80:289-304.
35. Sasaki YF, Imanishi H, Watanabe M, Ohta T, and Shirasu Y (1990) Suppressing effect of antimutagenic flavorings on chromosome aberrations induced by UV-light or X-rays in cultured Chinese hamster cells. Mutat Res 229:1-10.
36. Sato H and Seiki M (1993) Regulatory mechanism of 92 kDa type IVcollagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8:395-405.
37. Shattuck-Brandt RL and Richmond A (1997) Enhanced degradation of IκB-α contributes to endogenous activation of NF-κ B in Hs294T melanoma cells. Cancer Res 57:3032-3039.
38. Shaughnessy DT, Schaaper RM, Umbach DM, and DeMarini DM (2006) Inhibition of spontaneous mutagenesis by vanillin and cinnamaldehyde in Escherichia coli: dependence on recombinational repair. Mutat Res 602:54-64.
39. Stamenkovic I (2000) Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol 10:415-433.
40. Westermarck J and Kähäri VM (1999) Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J 13:781-792.